GlassScriptPhysician profile
Hila Gilberd
NPI 1184613911
$517.94
in general payments reported to CMS, 2019-2025
11 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.18 · 2022: $111 · 2023: $187 · 2024: $63.83 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $129.95 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $127.10 | 2021-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Cranial Technologies, INC | $51.68 | 2022-2025 | Doc Band |
| Sobi, INC | $50.40 | 2022-2023 | |
| Pfizer INC. | $32.75 | 2022-2023 | |
| Sanofi Pasteur INC. | $30.42 | 2023-2024 | |
| Cipher Pharmaceuticals US LLC | $21.78 | 2025 | Spinosad, Natroba |
| Ultragenyx Pharmaceutical INC. | $20.75 | 2022 | |
| Kyowa Kirin, INC. | $20.49 | 2023 | Crysvita |
| Ironshore Pharmaceuticals INC. | $18.58 | 2023 | Jornay Pm |
| Biomarin Pharmaceutical INC. | $14.04 | 2024 | Voxzogo 1.2mg |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hila Gilberd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.